Oral scopolamine hydrobromide solution as an antisialagogic agent in dentistry.
Antisialagogue, cardiac, and subjective effects of oral scopolamine hydrobromide solution (ScHBr), 0.02 mg/kg total body weight, were studied in a double-blind, randomized, placebo-controlled manner with ten healthy volunteers. ScHBr was rinsed in the mouth for 5 minutes before swallowing. ScHBr reduced nonstimulated and paraffin-stimulated salivation at 40 minutes by 52% and 62%, and at 60 minutes by 81% to 80%, respectively. The heart rate decreased significantly (p less than 0.01) when compared with placebo. With the same drug dosing method, the effects of ScHBr also were tested in clinical dental examination procedures in two dental student groups. In the ScHBr group, salivation decreased by 70%, and in the placebo group, it increased by 22% as a result of mechanical stimulus. Subjective sedation and relaxation were experienced by most of the volunteers.
Markkanen
Y J
YJ
Pihlajamäki
K
K
D000284:Administration, Oral; D000328:Adult; D003729:Dental Care; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D010919:Placebos; D011897:Random Allocation; D012463:Saliva / Q000378:metabolism; D012472:Salivation / Q000187:drug effects*; D012601:Scopolamine / Q000008:administration & dosage / Q000494:pharmacology*; D013997:Time Factors
D010919:Placebos; D012601:Scopolamine